N/A N=165 Tourniquet on Total Knee Arthroplasty
Arthritis Knee
Primary: Pain After TKA Measured by VAS Pain Survey on Focusmotion App — 2.8; 2.6 score on a scale
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=19 A Transparent Elasticized Adhesive Occlusive Compression Bandage for Use as an Arterial Tourniquet
Hemorrhage · Vascular Injury
Primary: Radiologist Limb Occlusion Assessment — 19; 18; 8; 8 Participants — p=0.002
N/A N=27 Tourniquets Increase Proximal Pressure
Blood Pressure
Primary: Systolic Blood Pressure During Application of the CAT Tourniquets — 129; 76 mmHg
N/A N=4 Temporary Aortic Occlusion With the Abdominal Tourniquet for Refractory Postpartum Haemorrhage: A Proof-of-Concept Study in a War-Affected Region
Postpartum Haemorrhage (PPH)
Primary: Time to Bleeding Control After AAJT-S Device Application — 2 Minutes
N/A N=73 Total Knee Replacement With Tourniquet or Aquamantys
Knee Replacement
Primary: Isometric Quadriceps Strength — 11.58; 9.60 Nm/kg
N/A N=60 Ischemic Preconditioning in Total Knee Arthroplasty
Total Knee Arthroplasty · Ischemic Preconditioning · Postoperative Pain
Primary: Postoperative Pain at Rest and Exercise as Assessed by Visual Analogue Scale (VAS) Scores at 48h After Surgery — 1.75; .71; 3; 1.38 score on a scale — p=.043
N/A N=12 Effect of Pneumatic Tourniquet on Arm Swelling After Lymph Node Removal
Healthy Subject
Primary: Change in Hand Volume Following Tourniquet Use — 15.0; 12.1; 12.5; 7.9 mL
N/A N=119 The Effect of Two Different Tourniquet Techniques on Peripheral IV Access Success Rates
Tourniquet
Primary: Peripheral IV Access Success Rate — 42; 43 Participants — p=0.95
N/A N=10 Assessment of Limb Perfusion During Junctional Tourniquet
Bleeding
Primary: Muscle Perfusion — 0.32; 0.10 IU/s
Phase 4 N=10 Performance of Junctional Tourniquets in Normal Human Volunteers
Hemorrhage
Primary: Effectiveness at Stopping Distal Pulse — 97; 27; 83; 93 percentage of participants
N/A N=355 Hemostasis With QuikClot® Radial® Pad Versus TR Band® After Transradial Artery Access
Coronary Artery Disease
Primary: Initial Successful Hemostasis — 85; 88; 51; 74 Participants — p=0.906
N/A N=30 Transradial-Band Pilot Study
Radial Artery Incision Site Closure
Primary: Percentage of Participants With Bleeding — 0; 1 Participants
Phase 4 N=24 Control of Tourniquet Pain With an Axillary Ring of Subcutaneous Local Anesthetic
Application Site Discomfort · Medical Device Discomfort
Primary: Time in Minutes That Tq Remained Inflated — 30.5; 22.4 Minutes
N/A N=253 Patent Hemostasis With Vasoband Versus TR Band
Radial Artery Injury at Wrist and Hand Level
Primary: Number of Patients Who Achieved Patent Hemostasis — 94; 122 Participants
N/A N=60 Assessment of a Novel Tracheostomy Tie
Tracheostomy Complication
Primary: Visual Analogue Scale to Measure the Difficulty Level of Exchanging or Cleaning the Tracheostomy Ties (0 to 10 ) Higher Scores Mean a Worse Outcome — 1.2; 7.5 score on a…
Phase 4 N=31 Femoral Peri-arterial Local Anesthetic Injection Decreases Tourniquet Associated Ischemic Hypertension
Tourniquet Hypertension · Intraoperative Hypertension · Total Ankle Arthroplasty
Primary: Number of Subjects Experiencing Tourniquet Hypertension — 5; 14 Participants
N/A N=154 Near-Infrared Spectroscopy for Pediatric Acute Scrotum and Testicular Torsion
Acute Scrotum · Testicular Torsion
Primary: Median NIRS Delta %StO2 — 2.0; -1.7 percentage of StO2
Phase 3 N=24 Regional Prophylactic Vancomycin With Restricted Tourniquet Time in Primary Total Knee Replacement
Arthropathy of Knee Joint
Primary: Vancomycin Concentration in Fat — 6.0; 40.5 ug/g — p=0.001
N/A N=70 Femoral Vein Hemostasis After Ablation for Atrial Fibrillation With Manual Pressure Versus a Figure of 8 Suture
Atrial Fibrillation
Primary: Time Required to Achieve Hemostasis — 0; 15 minutes
N/A N=75 Caring for the Radial Artery Post-angiogram
Transradial Angiogram
Primary: Bleeding Requiring Intervention After Initial Hemostasis Achieved — 2; 6; 3 participants — p=0.25
N/A N=20 Internal Jugular Vein Compression Collar for Novel Symptomatic Treatment of Venous Pulsatile Tinnitus
Pulsatile Tinnitus
Primary: Change From Baseline in Pulsatile Tinnitus Symptom Intensity — 3 units on a scale — p=<0.0001
N/A N=204 AMBULATE: Cardiva Mid-Bore VVCS vs. Manual Compression for Multiple Femoral Venous Access Sites, 6 - 12F ID
Surgical Wound
Primary: Time to Ambulation (TTA) — 2.8; 6.1 hours
Phase 4 N=58 Reducing Hemarthrosis in Tibial Tubercle Osteotomy by the Administration of Intravenous Tranexamic Acid
Tibial Tubercle Osteotomy
Primary: Perioperative Blood Loss — 67.8; 56.15 mL
N/A N=38 Quantifying the Venous Congestion Curve of a Tissue Oximetry Device
Post-Op Complication · Skin Flap Necrosis
Primary: Transcutaneous Oximetry (StO2) of Vascular Occlusion Test at 0.5 Hours — 70.353 percentage of oxygen saturation
Phase 4 N=150 Tranexamic Acid in Knee Joint Surgery
Osteoarthritis
Primary: Blood Loss — 1090; 716; 746 mls — p=<0.05
Phase 4 N=127 Clinical Trial Comparing Tranexamic Acid (TXA) With Aquamantys Sealer in Total Knee Arthroplasty (TKA)
Blood Loss
Primary: The Change in Hemoglobin (Hb) From the Day of Surgery — 2.6; 3.2; 2.6; 3.7 g/dl
N/A N=41 Trial of Blood Flow Restriction Plus Physical Therapy vs. Physical Therapy Alone for Lateral Epicondylitis
Lateral Epicondylitis
Primary: Change in Patient Rated Tennis Elbow Evaluation (PRTEE) — 7.63; 17.27 score on a scale
Phase 4 N=640 Randomized Controlled Trial of Tranexamic Acid in Total Knee Arthroplasty: Intravenous vs. Topical
Osteoarthritis
Primary: Total Blood Loss — 323.59; 271.22 ml
N/A N=111 Unipolar vs. Bipolar Hemostasis in Total Knee Arthroplasty: A Prospective Randomized Trial
Knee Arthroplasty
Primary: Drain Output. — 776; 778 mL
N/A N=50 Pre-hospital Advanced Therapies for Control of Hemorrhage - Pelvis
Hemorrhage · Pelvic Fracture
Primary: Mortality Rate — 0; 1 Participants